Line 233: | Line 233: | ||
</div> | </div> | ||
</div> | </div> | ||
+ | <div class="media"> | ||
+ | <img class="align-self-center mr-3" src="https://static.igem.org/mediawiki/2017/2/23/T--NYU_Abu_Dhabi--mazin.jpg | ||
+ | " alt="Generic placeholder image"> | ||
+ | <div class="media-body"> | ||
+ | <h5 class="mt-0">Secondary PI: Mazin Magzoub</h5> | ||
+ | Mazin Magzoub received his Ph.D. in Biophysics from Stockholm University (Stockholm, Sweden) studying the biophysical properties of cell-penetrating peptides. His lab focuses on drug delivery strategies, amyloid diseases, and cancer therapeutics. He currently serves as an Assistant Professor of Practice in Biology and as the Principal Investigator of the Biophysics Lab at NYUAD. | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
<h2 class="section-header">Instructors</h2> | <h2 class="section-header">Instructors</h2> | ||
Line 242: | Line 251: | ||
Ibrahim Chehade received his M.Sc. in Integrative Biology at Wilfrid Laurier University (Waterloo, Ontario, Canada) in the field of Environmental Toxicology and Endocrinology. He currently serves as an Associate Instructor of Biology at NYUAD. | Ibrahim Chehade received his M.Sc. in Integrative Biology at Wilfrid Laurier University (Waterloo, Ontario, Canada) in the field of Environmental Toxicology and Endocrinology. He currently serves as an Associate Instructor of Biology at NYUAD. | ||
</div> | </div> | ||
− | </div> | + | </div> |
− | + | ||
</div> | </div> | ||
Revision as of 14:55, 24 October 2017